Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RBX1
REST API REST API
Homo sapiens
RBX1 is differentially expressed in 129 experiments: 35 organism parts: prostate, stomach cardiac, ... (33 more);, 47 disease states: normal, breast carcinoma, ... (45 more);, 45 cell types 182 cell lines 18 compound treatments and 44 other conditions.
Synonyms ROC1, BA554C12.1, RNF75
Orthologs HRT1 (Saccharomyces cerevisiae)   RBX1 (Gallus gallus)   rbx1 (Danio rerio)   Rbx1 (Rattus norvegicus)   RBX1 (Bos taurus)   Roc1a (Drosophila melanogaster)   RBX1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, ligase activity, proteasomal ubiquitin-dependent protein catabolic process, protein binding, DNA repair, NEDD8 ligase activity, cytoplasm, protein ubiquitination, protein neddylation, metal ion binding, SCF ubiquitin ligase complex, Cul3-RING ubiquitin ligase complex, VCB complex, nucleus, ubiquitin-protein ligase activity, zinc ion binding, viral reproduction, Cul4B-RING ubiquitin ligase complex, SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, interspecies interaction between organisms, Cul4A-RING ubiquitin ligase complex
InterPro Term Znf_RING
UniProt Accession P62877
Search EB-eye ENSG00000100387
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-6573, E-MEXP-1251, E-GEOD-18105, E-MTAB-69, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-22152, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (15 experiments)

Factor Value U/D Experiments
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MCF-7
1
2
E-GEOD-20081, E-GEOD-19639, E-GEOD-5823
769P
1
E-MTAB-37
SKUT1
1
E-MTAB-37
HCC1395
1
E-MTAB-37
Toledo
1
E-MTAB-37
176 more value(s).


Cell type

studied in E-GEOD-10797, E-GEOD-18811, E-MEXP-2488, E-GEOD-22373, E-GEOD-6053, ... (22 experiments)

Factor Value U/D Experiments
fetal RPE
1
E-GEOD-18811
parental foreskin cells
1
E-GEOD-20033
articular cartilage
1
E-MEXP-2488
adipose-derived stem cell
1
E-MEXP-1216
PBMCs
1
E-GEOD-20677
undifferentiated cell
1
E-GEOD-21668
39 more value(s).


Disease state

studied in E-GEOD-19743, E-GEOD-6872, E-GEOD-21912, E-TABM-311, E-GEOD-12254, ... (22 experiments)

Factor Value U/D Experiments
control
2
E-GEOD-21912, E-GEOD-16363
plasma cell myeloma
1
E-MTAB-37
viral hemorrhagic fever
1
E-GEOD-12254
clear cell renal carcinoma
1
E-TABM-282
T-cell acute lymphoblastic leukemia
1
E-MTAB-37
ovarian carcinoma
1
E-MTAB-37
41 more value(s).


Compound treatment

studied in E-MEXP-1601, E-GEOD-20719, E-GEOD-15205, E-TABM-782, E-GEOD-3720, ... (11 experiments)

Factor Value U/D Experiments
none
1
3
E-MEXP-1601, E-MEXP-1958, E-GEOD-20719, E-TABM-782
lipopolysaccharide
2
E-MEXP-1958, E-GEOD-3720
TNF
1
E-GEOD-15205
resveratrol
1
E-TABM-782
anti-CD3 antibody (clone:OKT3)
1
E-MEXP-1601
cigarette smoke
1
E-TABM-127
12 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19480

Clinical history
studied in E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er ihc
studied in E-GEOD-21653

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-17385, E-GEOD-20847

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-MEXP-421, E-GEOD-17347

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-GEOD-12773, E-TABM-127, ... (8 experiments)

Histology
studied in E-TABM-234, E-TABM-276

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-GEOD-19330, E-TABM-666, ... (14 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-21750

Pr ihc
studied in E-GEOD-21653

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-18791

RNAi
studied in E-MEXP-1509, E-GEOD-3697, E-MEXP-1857, E-MEXP-1315

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797

Sex
studied in E-GEOD-1643, E-GEOD-16363

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19815, E-GEOD-15799, ... (6 experiments)

Processing time: 0.338 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM